To explore the clinical efficacy of herniorrhaphy and open decompression in the treatment of (ACS) with abdominal infection in patients with celiac compartment syndrome, and to analyze its application value.

From April 2011 to April 2018, 44 cases of ACS with abdominal infection were analyzed retrospectively. Among them, 18 cases were treated with herniorrhaphy and 24 cases were treated with open decompression. The clinical data of patients before and after treatment were collected, the therapeutic effects of patients after treatment were compared, the APACHEⅡ scores of patients before and after treatment were compared, and the changes of serum inflammatory factors CRP, IL-6 and TNF-α before and after treatment were compared.

The two groups of patients improved their treatment and had certain curative effect. The total effective rate of the experimental group (83.33%) was higher than that of the control group (79.17%), but there was no significant difference (P=0.773). The APACHEⅡ scores of the two groups were decreased after treatment. The degree of decline was greater than that of the control group (P<0.01). After treatment, the inflammatory response was significantly relieved, and the inflammatory markers CRP, IL-6, and TNF-α were decreased. There were statistical differences before and after treatment, and the degree of inflammation was significantly reduced in the experimental group. Greater than the control group (P<0.01).

Herniorrhaphy for clinical treatment of ACS with abdominal infection can effectively improve serum inflammatory factor levels, alleviate clinical symptoms, improve patient health, reduce intra-abdominal pressure, and provide new options for clinical treatment.